Nanodiscs as a therapeutic delivery agent: Inhibition of respiratory syncytial virus infection in the lung

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 1417-1427

  Numata, Mari ^a   Grinkova, Yelena V ^b   Mitchell, James R ^a   Chu, Hong Wei ^a   Sligar, Stephen G ^b   Voelker, Dennis R ^a  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Anti viral; Innate immunity; Nanodiscs; Phospholipids; Therapeutic delivery

Indexed keywords

APOLIPOPROTEIN A1; GAMMA INTERFERON; INTERLEUKIN 8; LUNG SURFACTANT; NANODISC; PALMITOYLOLEOYLPHOSPHATIDYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG POTENCY; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG PARENCHYMA; MOUSE; NONHUMAN; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIRUS ATTACHMENT; VIRUS ATTENUATION; VIRUS INHIBITION; VIRUS PARTICLE;

ANTI-VIRAL; INNATE IMMUNITY; NANODISCS; PHOSPHOLIPIDS; THERAPEUTIC DELIVERY;

ADMINISTRATION, INTRANASAL; ANALYSIS OF VARIANCE; ANIMALS; ANTIVIRAL AGENTS; APOLIPOPROTEIN A-I; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; INTERLEUKIN-8; LIPID BILAYERS; LUNG; MICE; MICE, INBRED BALB C; MOLECULAR DYNAMICS SIMULATION; NANOSTRUCTURES; PHOSPHATIDYLGLYCEROLS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; VIRUS ATTACHMENT; VIRUS CULTIVATION;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 84876263344     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S39888     Document Type: Article

References (30)

1. Bayburt TH, Grinkova YV, Sligar SG. Self-assembly of discoidal phospholipid bilayer nanoparticles with membrane scaffold proteins. Nano Letters. 2002;2(8):853-856.
2. Denisov IG, Grinkova YV, Lazarides AA, Sligar SG. Directed self-assembly of monodisperse phospholipid bilayer nanodiscs with controlled size. J Am Chem Soc. 2004;126(11):3477-3487.
3. Grinkova YV, Denisov IG, Sligar SG. Engineering extended membrane scaffold proteins for self-assembly of soluble nanoscale lipid bilayers Protein Engineering, Design and Selection. 2010;23(11):843-848. doi: 10.1093/protein/gzq060.
4. Atkinson D, Small DM. Recombinant lipoproteins: implications for structure and assembly of native lipoproteins. Annu Rev Biophys Biophys Chem. 1986;15:403-456.
5. Atkinson D, Smith HM, Dickson J, Austin JP. Interaction of apoprotein from porcine high-density lipoprotein with dimyristoyl lecithin. 1. The structure of the complexes. Eur J Biochem. 1976;64(2):541-547.
6. Brouillette CG, Anantharamaiah GM, Engler JA, Borhani DW. Structural models of human apolipoprotein A-I: a critical analysis and review. Biochim Biophys Acta. 2001;1531(1-2):4-46.
7. Brouillette CG, Jones JL, Ng TC, Kercret H, Chung BH, Segrest JP. Structural studies of apolipoprotein A-I/phosphatidylcholine recombinants by high-field proton NMR, nondenaturing gradient gel electrophoresis, and electron microscopy. Biochemistry. 1984;23(2):359-367.
8. Jonas A. Reconstitution of high-density lipoproteins. Methods Enzymol. 1986;128:553-582.
9. Matz CE, Jonas A. Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J Biol Chem. 1982;257(8):4535-4540.
10. Segrest JP. Amphipathic helixes and plasma lipoproteins: thermodynamic and geometric considerations. Chem Phys Lipids. 1977;18(1): 7-22.
11. Wlodawer A, Segrest JP, Chung BH, Chiovetti R Jr, Weinstein JN. High-density lipoprotein recombinants: evidence for a bicycle tire micelle structure obtained by neutron scattering and electron microscopy. FEBS Lett. 1979;104(2):231-235.
12. Fielding CJ, Fielding PE. Dynamics of lipoprotein transport in the circulatory system. In: Vance DE, Vance JE, editors. Biochemistry of Lipids, Lipoproteins and Membranes, 5th ed. Amsterdam: Elsevier; 2008:533-553.
13. Zannis VI, Chroni A, Krieger M. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. J Mol Med (Berl). 2006;84(4):276-294.
14. Marcel YL, Kiss RS. Structure-function relationships of apolipoprotein A-I: a flexible protein with dynamic lipid associations. Curr Opin Lipidol. 2003;14(2):151-157.
15. Nath A, Atkins WM, Sligar SG. Applications of phospholipid bilayer nanodiscs in the study of membranes and membrane proteins. Biochemistry. 2007;46(8):2059-2069.
16. Sligar SG. Finding a single-molecule solution for membrane proteins. Biochem Biophys Res Commun. 2003;312(1):115-119.
17. Ritchie TK, Grinkova YV, Bayburt TH, et al. Reconstitution of membrane proteins in phospholipid bilayer nanodiscs. Methods Enzymol. 2009;464:211-231.
18. Bayburt TH, Sligar SG. Membrane protein assembly into nanodisks. FEBS Letters. 2010;584(9):1721-1727.
19. Denisov IG, Sligar SG. Cytochromes P 450in nanodiscs. Biochim Biophys Acta. 2011;1814(1):223-229.
20. Simoes EA. Respiratory syncytial virus infection. Lancet. 1999;354(9181):847-852.
21. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352(17):1749-1759.
22. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med. 2001;344(25):1917-1928.
23. Numata M, Chu HW, Dakhama A, Voelker DR. Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection. Proc Natl Acad Sci U S A. 2010;107(1):320-325.
24. Cimolai N, Taylor GP, Mah D, Morrison BJ. Definition and application of a histopathological scoring scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection. Microbiol Immunol. 1992;36(5):465-478.
25. Dakhama A, Park JW, Taube C, et al. The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production. J Immunol. 2005;175(3):1876-1883.
26. LeVine AM, Elliott J, Whitsett JA, et al. Surfactant protein-D enhances phagocytosis and pulmonary clearance of respiratory syncytial virus. Am J Respir Cell Mol Biol. 2004;31(2):193-199.
27. McKimm-Breschkin JL. A simplified plaque assay for respiratory syncytial virus-direct visualization of plaques without immunostaining. J Virol Methods. 2004;120(1):113-117.
28. Numata MKP, Nagashima Y, Posey J, Hartshorn K, Woodland D, Voelker DR. Phosphatidylglycerol suppresses influenza A virus infection. Am J Respir Cell Mol Biol. 2012;46:479-487.
29. Hallman M, Merritt TA, Bry K. The fate of exogenous surfactant in neonates with respiratory distress syndrome. Clin Pharmacokinet. 1994;26(3):215-232.
30. Shih, AY, Denisov IG, Phillips JC, Sligar SG, Schulten K. Molecular dynamics simulations of discoidal bilayers assembled from truncated human lipoproteins. Biophys J. 2005;88:548-556.